2004
DOI: 10.1158/1535-7163.1411.3.11
|View full text |Cite
|
Sign up to set email alerts
|

8-Amino-adenosine is a potential therapeutic agent for multiple myeloma

Abstract: Multiple myeloma (MM) is a malignancy of clonal B-cells that accounts for 10% of all hematologic malignancies. We have shown previously that a novel purine analogue, 8-chloro-adenosine, has significant activity for MM in preclinical studies. Objective: Using MM cell lines, we investigated the molecular mechanism of related congener of adenosine, 8-amino-adenosine (8-NH2-Ado). Methods: We employed biological and biochemical assays in MM cell lines to evaluate the clinical potential of 8-NH2-Ado. Results: In MM … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 30 publications
(8 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…Compound 4 was also shown to inhibit the growth of human colon tumor 116 (HCT116) cells in a sulforhodamine B (SRB) growth inhibition assay (GI 50 0.05 µM). 16,17 The cytotoxic activity of 4 has been previously reported, 18 but the mismatch between HSP70 FP IC 50 and HCT116 GI 50 , and later PD marker studies (see below), indicated that the cytotoxic mechanism of action of compound 4 must be predominantly through a route other than HSP70 inhibition.…”
mentioning
confidence: 96%
“…Compound 4 was also shown to inhibit the growth of human colon tumor 116 (HCT116) cells in a sulforhodamine B (SRB) growth inhibition assay (GI 50 0.05 µM). 16,17 The cytotoxic activity of 4 has been previously reported, 18 but the mismatch between HSP70 FP IC 50 and HCT116 GI 50 , and later PD marker studies (see below), indicated that the cytotoxic mechanism of action of compound 4 must be predominantly through a route other than HSP70 inhibition.…”
mentioning
confidence: 96%
“…Several studies have shown that 8-chloroadenosine (8-Cl-Ado) and 8-NH2-Ado have strong hematological toxicity through their ability to inhibit RNA synthesis, and 8-Cl-Ado is currently in a Phase I clinical study for patients with chronic lymphocytic leukemia. [11][12][13][14][15] 8-NH2-Ado was reported to be more potent as shown by induction of apoptosis-related cleavage of poly (ADP-ribose) polymerase compared with 8-Cl-Ado. Furthermore, the intracellular accumulation of 8-NH2-ATP is 38-fold higher than that of 8-Cl-ATP in leukemia cells and leads to greater analogue-mediated declines in the ATP pool and mRNA synthesis.…”
Section: Discussionmentioning
confidence: 99%
“…Adenosine and 8-NH 2 -Ado are known to be converted to ATP and 8-NH2-ATP by adenosine kinase and other enzymes. 11) If phosphorylation of 8-NH2-Ado is essential to lead the radiosensitization and this phosphorylation reaction is a competitive reaction to the same enzyme for adenosine, addition of exogenous adenosine to the culture medium seems to ameliorate the killing effect of 8-NH2-Ado. Thus, to examine the effect of adenosine on 8-NH2-Ado-induced apoptosis and intracellular ATP level, A549 cells were cotreated with the large amounts (10 μM-500 μM) of adenosine and 10 μM 8-NH2-Ado for 24 h. As shown in Fig.…”
Section: Adenosine Suppressed Enhancement Of Radiationinduced Apoptos...mentioning
confidence: 99%
See 2 more Smart Citations